Are HIV positive patients resistant to statin therapy?
<p>Abstract</p> <p>Background</p> <p>Patients with HIV are subject to development of HIV metabolic syndrome characterized by dyslipidemia, lipodystrophy and insulin resistance secondary to highly active antiretroviral therapy (HAART). Rosuvastatin is a highly potent HMG...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | Lipids in Health and Disease |
Online Access: | http://www.lipidworld.com/content/6/1/27 |